Suchergebnisse - "Mauss, Stefan"

PubPharm (17)

1

Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2016

von Zimmermann, T. | Hueppe, D. | Mauss, S. | +5

2

Dual treatment of acute HCV infection in HIV co-infection : influence of HCV genotype upon treatment outcome

enthalten in: Infection | 2016

von Boesecke, C. | Ingiliz, P. | Reiberger, T. | +13

3

Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders

enthalten in: Journal of hepatology | 2015

von Jensen, D. | Sherman, K. | Hézode, C. | +21

4

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

enthalten in: PloS one | 2015

von Hofmann, W. | Mauss, S. | Lutz, T. | +10

5

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

enthalten in: World journal of gastroenterology | 2014

von Roeder, C. | Jordan, S. | Schulze Zur Wiesch, J. | +8

6

SILEN-C3, a phase 2 randomized trial with faldaprevir plus pegylated interferon α-2a and ribavirin in treatment-naive hepatitis C virus genotype 1-infected patients

enthalten in: Antimicrobial agents and chemotherapy | 2014

von Dieterich, D. | Asselah, T. | Guyader, D. | +12

7

Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice

enthalten in: European journal of gastroenterology & hepatology | 2014

von Niederau, C. | Mauss, S. | Böker, K. | +7

8

Chronic hepatitis B treatment initiation and modification patterns in five European countries : a 2-year longitudinal, non-interventional study

enthalten in: Antiviral therapy | 2014

von Marcellin, P. | Arama, V. | Leblebicioglu, H. | +59

9

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype 1 HCV : SILEN-C1 trial

enthalten in: Hepatology (Baltimore, Md.) | 2013

von Sulkowski, M. | Asselah, T. | Lalezari, J. | +13

10

Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse : SILEN-C2 trial

enthalten in: Hepatology (Baltimore, Md.) | 2013

von Sulkowski, M. | Bourlière, M. | Bronowicki, J. | +13